2016
DOI: 10.1016/j.immuni.2015.11.009
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells

Abstract: Interleukin-23 (IL-23) is a pro-inflammatory cytokine required for the pathogenicity of T helper 17 (Th17) cells but the molecular mechanisms governing this process remain unclear. We identified the transcription factor Blimp-1 (Prdm1) as a key IL-23-induced factor that drove the inflammatory function of Th17 cells. In contrast to thymic deletion of Blimp-1, which causes T cell development defects and spontaneous autoimmunity, peripheral deletion of this transcription factor resulted in reduced Th17 activation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
117
2
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 136 publications
(128 citation statements)
references
References 36 publications
6
117
2
2
Order By: Relevance
“…For example, both Blimp-1 and G9a are required to limit Th17 cell development in a cell-intrinsic manner (15, 123). However, the increased frequency of Th17 cells does not result in enhanced pathogenicity of inflammatory diseases such as EAE or intestinal inflammation (15, 124), demonstrating that reducing the activity of Blimp-1 or G9a, or by inhibiting their interaction, may be a viable method to reduce the development of pathogenic Th17 cells. Future studies will define the precise role of G9a in immune cell development, differentiation, and function and determine the relevance of G9a as a drug target to treat inflammatory disease.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, both Blimp-1 and G9a are required to limit Th17 cell development in a cell-intrinsic manner (15, 123). However, the increased frequency of Th17 cells does not result in enhanced pathogenicity of inflammatory diseases such as EAE or intestinal inflammation (15, 124), demonstrating that reducing the activity of Blimp-1 or G9a, or by inhibiting their interaction, may be a viable method to reduce the development of pathogenic Th17 cells. Future studies will define the precise role of G9a in immune cell development, differentiation, and function and determine the relevance of G9a as a drug target to treat inflammatory disease.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, IL-23-induced Blimp-1 has been shown to be critical for the development of inflammatory Th17 cells that are required for the pathogenesis of EAE (124). Thus, mice lacking Blimp-1 in T cells fail to develop EAE.…”
Section: Interactions and Potential Roles Of G9amentioning
confidence: 99%
“…Ndfip1-deficient Th17 cells do not show increased levels of IL-23R mRNA compared to WT cells, however we have not explored IL23R protein levels or protein levels of Blimp1. Blimp1 can also increase the production of IFNγ, GM-CSF, and IL-17A from Th17 cells817. Interestingly, Blimp1, like RORγT, contains an LPXY motif that would allow binding to Itch.…”
Section: Discussionmentioning
confidence: 99%
“…Such exposure results in the formation of a complex that contains the transcription factors Blimp1, RORγT, STAT3, p300, HIF1α, BATF and IRF4. Together, these factors cooperate to drive the expression of genes such as il17a, il23r and csf2 817. Furthermore, pathogenic Th17s have been reported to show a gene profile that includes tbx21, csf2 and ccl5 (Rantes), among others18.…”
mentioning
confidence: 99%
“…Th17 cells differentiate from naïve Th0 cells under conditions of inflammation, driven by signals from TGFβ, IL-6, IL-1 and IL-21 [5]. During differentiation, Th17 cells express the IL-23 receptor (IL-23R), and signals from IL-23 are necessary for these cells to be pathogenic [69]. Indeed, antibodies against IL-17A and IL-23 are effective in treating autoimmunity, particularly plaque psoriasis [10, 11].…”
Section: Introductionmentioning
confidence: 99%